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Comprehensive clinical studies show that adverse conditions in early life can severely impact the 
developing brain and increase vulnerability to mood disorders later in life. During early postnatal 
life the brain exhibits high plasticity which allows environmental signals to alter the trajectories 
of rapidly developing circuits. Adversity in early life is able to shape the experience-dependent 
maturation of stress-regulating pathways underlying emotional functions and endocrine 
responses to stress, such as the hypothalamo–pituitary–adrenal (HPA) system, leading to long-
lasting altered stress responsivity during adulthood. To date, the study of gene–environment 
interactions in the human population has been dominated by epidemiology. However, recent 
research in the neuroscience field is now advancing clinical studies by addressing specifically 
the mechanisms by which gene–environment interactions can predispose individuals toward 
psychopathology. To this end, appropriate animal models are being developed in which early 
environmental factors can be manipulated in a controlled manner. Here we will review recent 
studies performed with the common aim of understanding the effects of the early environment 
in shaping brain development and discuss the newly developing role of epigenetic mechanisms 
in translating early life conditions into long-lasting changes in gene expression underpinning brain 
functions. Particularly, we argue that epigenetic mechanisms can mediate the gene–environment 
dialog in early life and give rise to persistent epigenetic programming of adult physiology and 
dysfunction eventually resulting in disease. Understanding how early life experiences can 
give rise to lasting epigenetic marks conferring increased risk for mental disorders, how they 
are maintained and how they could be reversed, is increasingly becoming a focus of modern 
psychiatry and should pave new guidelines for timely therapeutic interventions.
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(HPA)  system  –  an  integral  component  of  the  body’s  stress 
response – leading to increased stress responsivity in adulthood 
(for  review  see  Seckl  and  Meaney,  2004).  Indeed,  depressed 
patients with a history of childhood abuse or neglect are often 
characterized by hyperactivity of the HPA axis (for review see 
Heim and Nemeroff, 2002).
To understand gene–environment interactions in human popu-
lations, and to elucidate the pathways through which programming 
in response to early life experiences is mediated, researchers in the 
neuroscience field rely on animal models in which the early envi-
ronment can be manipulated in a controlled fashion. Current work 
suggests that so-called epigenetic mechanisms of gene regulation, 
which alter the activity of genes without changing the order of their 
DNA sequence, could explain how early life experiences can leave 
indelible chemical marks on the brain and influence both physical 
and mental health later in life even when the initial trigger is long 
gone (for review see Dudley et al., 2011).
In this review we highlight recent animal and human studies 
addressing epigenetic regulation of gene expression in sustaining 
the effects of early life experiences. Hereby, we focus on clinical and 
animal studies that have investigated how biological stress systems, 
particularly the HPA axis, are shaped by adversity and then provide 
a description of what we know about the function of epigenetic 
systems and their roles in brain development and disease. The 
dynamic nature of epigenetic mechanisms may have   important 
IntroductIon
The close relationship between the quality of early life and mental 
health in later life is a longstanding certainty (Gluckman et al., 
2008). Many studies in humans, primates, and rodents illustrate 
that aspects of the early environment can lead to dramatic changes 
in physical and mental development compromising cardiovascu-
lar and metabolic diseases, altered cognition, mood, and behav-
ior. In particular, adverse conditions during early life periods of 
development can shape individual differences in vulnerability to 
stress-related disorders throughout life (for review see Heim and 
Nemeroff, 2002), dependent on the degree of “match” and “mis-
match” between early and later life environments.
These findings raise the intriguing question of how these expe-
riences become incorporated at the cellular and molecular level in 
the brain architecture leading to long-term alterations in various 
functions ultimately culminating in an increased risk to mental 
disease. Developmental plasticity defines an organism’s ability 
to adapt to the environment during early life and to implement 
long-lasting changes in sets of key biological programs on the 
assumption that the environmental conditions during this early 
period will persist throughout later life (for review see Hochberg 
et al., 2010). Adverse maternal experience during early life might 
profoundly  influence  the  experience-dependent  maturation 
of structures underlying emotional functions and endocrine 
responses to stress, such as the   hypothalamo–  pituitary–  adrenal Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    April 2011  | Volume 2  | Article 16  |  2
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with the length of time spent in this type of postnatal environment 
(e.g., O’Connor and Rutter, 2000). These findings are supported by 
longitudinal studies of abuse and neglect that indicate increased risk 
of cognitive impairment, social and emotional difficulties, and risk 
of mental and physical disease, with those later manifesting post-
traumatic stress disorder showing smaller cerebellar and cerebral 
volumes correlating with earlier onsets and increased durations 
of abuse (e.g., De Bellis and Kuchibhatla, 2006). Furthermore, in 
adulthood, the experience of childhood abuse or neglect is tightly 
associated with increased HPA axis activity (e.g., Carpenter et al., 
2010).
Early lIfE advErsIty shapEs thE hpa axIs
On exposure to a stressor a body activates stress systems to pre-
pare for events that may threaten well-being or survival. The auto-
nomic nervous system initiates a rapid and relatively short-lived 
“  fight-or-flight” response while the HPA axis is slower, instigating 
a more protracted response. The HPA axis is therefore core to the 
long-term regulation of systems controlling stress responsivity.
Following  exposure  to  a  stressor,  the  neuropeptides 
  corticotropin-releasing hormone (CRH) and arginine vasopressin 
(AVP) are released from the paraventricular nucleus (PVN) of the 
hypothalamus into the portal vessel system. These neuropeptides 
bind to and activate specific receptors (the CRHR1 and V1b recep-
tors for CRH and AVP, respectively) on anterior pituitary cortico-
troph cells stimulating the release of adrenocorticotrophic hormone 
(ACTH) which then acts on the adrenal cortex to synthesize and 
release glucocorticoid hormones (cortisol in primates and corticos-
terone in rats). Glucocorticoids mobilize glucose from energy stores 
and increase cardiovascular tone, among further widespread effects. 
Feedback loops, primarily mediated by the PVN and pituitary cor-
ticotroph  cells,  through  glucocorticoid  receptors  (GR)  restrain 
responsiveness of the HPA axis to reset the system to baseline activity 
(Figure 1; for review see De Kloet et al., 1998). In short, the forward 
loop prepares the organism to anticipate and respond optimally to 
a threat, while the feedback loop ensures returning efficiently to a 
homeostatic balance when it is no longer challenged.
Following periods of sustained stress, negative feedback control 
of the HPA axis can become dysregulated and this may underlie the 
development of disorders such as major depression (for review see 
Holsboer, 2000). Indeed, altered activity of this circuit is one of the 
most commonly observed neuroendocrine symptoms in patients 
suffering from major depressive disorder (MDD) and dysregulation 
of cortisol secretion can be found in as many as 80% of depressed 
patients if subjects are clustered into different age ranges (Heuser 
et al., 1994).
In clinical studies early life stress has been shown to be a strong 
predictor of impaired inhibitory feedback regulation of the HPA 
axis (Heim et al., 2008) as deduced by dexamethasone/CRH chal-
lenge tests. Clinical findings give strong evidence to assume that 
depression is characterized by a hypothalamic overdrive of CRH 
and/or AVP systems. Postmortem studies of brain tissue reveal 
elevated CRH (Raadsheer et al., 1994) and AVP (e.g., Meynen 
et al., 2006) in the hypothalamus of depressed individuals. In 
cerebrospinal fluid increased concentrations of CRH have been 
reported to associate with depression, PTSD and obsessive–com-
pulsive disorder (e.g., Bremner et al., 1997;) while higher plasma 
implications when considering the possibility of therapeutic inter-
ventions, wherefore we conclude on current evidences of this new 
research field for the treatment of mental diseases.
chIldhood dEcIdEs
Sigmund Freud postulated that the trauma of birth – disrupting 
the physical symbiosis between fetus and mother – becomes a 
central force in our adult life. This fear and experience of abandon-
ment is a deep-rooted subject in psychology. According to Bowlby 
(1982), attachment processes are central to understanding anxi-
ety, as illustrated in his decades long studies of children and their 
attachments to their caregivers, where infants demonstrate distress 
upon impending departure of the mother as soon as they are old 
enough to sense signs that she is leaving – around 6–9 months 
(Sartre,1964).
It has been suggested that a mother’s external regulation of the 
infant’s developing immature emotional systems during selected 
critical periods may represent the essential factor influencing the 
experience-dependent growth of brain areas and structures impor-
tant in regulating mood and behavior. Attachment behaviors could 
therefore be considered a biological system, interrelated with the 
fear and stress system, evolved specifically to increase the likeli-
hood of infant–parent proximity which, in turn ensures increased 
chances of survival of the infant. Indeed, the attachment system 
is activated especially in times of stress, and the availability of an 
attachment figure such as the mother, has a great influence in reduc-
ing a child’s fearfulness (for review see Schore, 2000). However, 
frequent or prolonged bouts of abandonment can lead to the stress 
becoming a part of the infant’s and, later, the adult’s personality. 
Unfortunately, such situations are all too common where infants 
are inhibited from forming attachments by either being raised 
without the stimulation and attention of a regular caregiver, or 
suffering abuse or extreme neglect; conservative estimates suggest 
that each year in the United States, more than 1,000,000 children 
are exposed to such conditions (Sedlak and Broadhurst, 1996). The 
possible short-term effects of this are anger, despair, detachment, 
and temporary delay in intellectual development while long-term 
effects can include psychosomatic disorders, and increased risk of 
depression or anxiety.
Studies of institutionally reared children have been instrumental 
in understanding the long-term consequences of childhood social 
deprivation and have revealed the presence of cognitive, social, and 
physical deficits (e.g., Rutter, 1998), with good reason to consider 
emotional neglect as the major precipitating factor (for review 
see Tarullo and Gunnar, 2006). These observations are consistent 
with the view that early social interactions play a significant role 
in the development of basic affective processes, supporting learn-
ing through connections between cues, situations, and emotional 
experiences. In support, post-institutionalized children demon-
strate significant difficulty matching appropriate facial expres-
sions to happy, sad, and fearful scenarios (Fries and Pollak, 2004). 
Reports on post-institutionalized children from Romania reveal 
the development of difficulties in forming emotional attachments 
to adoptive caregivers, providing further validation for the attach-
ment disorder construct; moreover, these children display irregular 
glucose metabolic rates in brain regions controlling cognitive and 
emotional functions, and an increased HPA axis activity associated www.frontiersin.org  April 2011  | Volume 2  | Article 16  |  3
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  sensitivity of GR-mediated negative feedback regulation of the 
HPA axis in depression, which would appear to result from a shift 
toward increased AVP secretion.
ModElIng Early advErsE ExpErIEncEs
Given that early life stress may lead to enduring dysregulation of the 
HPA axis and the close link between HPA dysfunction and major 
depression it has been suggested that early life stress may predis-
pose individuals to psychiatric diseases in later life. Evidently there 
are ethical limitations to conducting prospective early life stress 
experiments in human participants. Therefore, animal models are 
invaluable in gaining insight into the behavioral and physiological 
mechanisms underlying the long-term effects of early experiences 
on emotional reactivity and the stress response.
Rodents are particularly well suited to studies of the effects of 
early life experience as it is possible to rear them in large numbers 
and under controlled environmental conditions. Even quite sub-
tle alterations in the experience of rats during the early postnatal 
or prenatal periods can provoke long enduring consequences in 
behavioral and endocrine phenotypes (for review see Holmes et al., 
2005). Acknowledging attachment theories, many of these models 
investigate adverse early life factors by focusing on the preeminent 
mother–infant relationship.
Early lIfE strEss
One of the most widely studied models for early life stress is mater-
nal separation (MS) in which rodents are separated for around 3 h 
per day for the first 2 weeks of life. Whether the exact psychologi-
cal cause of the effects of postnatal MS stress results as a direct 
effect of the pup itself, or indirectly though the manipulation of 
the mother is still not completely understood: either simulating 
maternal stroking and feeding during the separation period or pro-
viding the dams with a foster litter during the period of separation 
from their own pups can both dampen the effects of MS on later 
stress hyper-reactivity (e.g., van Oers et al., 1999; Huot et al., 2004). 
This procedure can result in persistent increases in anxiety-related 
behaviors and life-long hyperactivity of the HPA axis in response 
to stressors (for review see Holmes et al., 2005). Early life stress can 
also induce long-term effects on hippocampal associated cognitive 
function and memory (e.g., Eiland and McEwen, 2010) with grow-
ing evidence suggesting that the paradigm can disrupt development 
of neural systems mediating reward-related behaviors, as evident 
from increases in voluntary ethanol consumption and exaggerated 
responses to psychostimulants (e.g., Lopez et al., 2010), support-
ing the concept that maternal and infant attachment is a reward-
mediated behavior (e.g., Moles et al., 2004).
Elucidation of neuroendocrine changes underlying the persist-
ent effects of early life stress in rodents has become a major research 
area. A growing number of reports has documented permanent 
increases in neurotransmission and hypothalamic expression of 
CRH (e.g., Vazquez et al., 2006) and AVP (e.g., Veenema et al., 2006) 
following early life stress. In addition, the ability of hippocampal 
GRs to attenuate HPA axis may be persistently disrupted; rats sub-
jected to postnatal MS exhibit significantly reduced expression of 
forebrain GRs and an impairment of the synthetic glucocorticoid 
dexamethasone to suppress HPA axis activity in adults (e.g., Ladd 
et al., 2004).
levels of AVP have been noted in depression (e.g., Goekoop et al., 
2006). Receptors for the hormones also appear to be altered in 
depression with reduced CRH binding sites being detected in the 
frontal cortex (Nemeroff et al., 1988) and reduced ACTH responses 
to CRH (Rupprecht et al., 1989). A recent study further suggested 
that variations in the CRH receptor1 gene moderated the effect 
of childhood maltreatment on cortisol responses to a dexametha-
sone/CRH test (Tyrka et al., 2009) and mutation screens have 
linked polymorphisms in the V1b and AVP genes with childhood-
onset depression (e.g., Dempster et al., 2009), supporting previous 
preclinical work in which selective inbreeding of rodents for high 
levels of anxiety-like behavior inadvertently enriches for altera-
tions in the AVP gene (Murgatroyd et al., 2004; Kessler et al., 2007; 
Bunck et al., 2009).
Studies in rodent models demonstrate that exposure to chronic 
stress can dramatically alter the balance between AVP and CRH 
control of the HPA axis. For instance, repeated exposure to a stres-
sor leads to enhanced expression of AVP in the PVN, an increase 
in the number of CRH-containing neurons that co-express AVP 
and elevation of V1b receptor mRNA in the pituitary – data con-
sistent with the hypothesis that under circumstances of sustained 
stress AVP becomes the driving force in regulation of the HPA 
axis (Aguilera and Rabadan-Diehl, 2000). In further support, in 
vitro studies have shown that stimulation of ACTH release by AVP 
is less sensitive to negative feedback control by glucocorticoids 
in comparison with ACTH responses to CRH (e.g., Bilezikjian 
et al., 1987). Conclusively, these data suggest a reduction in the 
Figure 1 | The hypothalamo–pituitary–adrenal (HPA) stress axis. The 
neuropeptides corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) are expressed in the parvocelluar neurons of the 
hypothalamic nucleus paraventricularis. The joint release of CRH and AVP into 
the portal blood vessels leads to potent stimulation of anterior pituitary ACTH 
secretion and in turn of corticosterone from the adrenal glands. The 
activational effects of the HPA axis are counteracted by the inhibitory effects 
of glucocorticoid receptors expressed in the hippocampus, hypothalamus, and 
anterior pituitary.Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    April 2011  | Volume 2  | Article 16  |  4
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arise during development and are subsequently retained through 
mitosis. The term epigenetics is now commonly used to describe 
the study of stable alterations in gene expression potential that arise 
during development, differentiation and under the influence of the 
environment (for review see Jaenisch and Bird, 2003). In contrast 
to DNA sequence that is identical in all tissues, the patterns of 
epigenetic marks are tissue-specific. Hence, a genome can be con-
sidered to contain two layers of information: the DNA sequence 
inherited from our parents which are conserved throughout life and 
mostly identical in all cells and tissues of our body, and epigenetic 
marks (i.e., chromatin and DNA methylation patterns) which are 
cell- and tissue-specific.
Epigenetic regulation of gene expression therefore allows the 
integration of intrinsic and environmental signals in the genome, 
thus facilitating the adaptation of an organism to changing envi-
ronment through alterations in gene activity. In this way, epige-
netics could be thought of as conferring additional plasticity to 
the hard-coded genome. In the context of the early life environ-
ment, epigenetic changes offer a plausible mechanism by which 
early experiences could be integrated into the genome to program 
adult hormonal and behavioral responses.
The epigenome refers to the ensemble of coordinated epigenetic 
marks that govern accessibility of the DNA to the machinery driving 
gene expression; inaccessible genes become silenced whereas acces-
sible genes are actively transcribed. Although the understanding of 
the interplay between epigenetic modifications is still evolving, the 
modification of core histones that package the DNA into chromatin 
and methylation of DNA at the cytosine side-chain in cytosine– 
guanine (CpG) dinucleotides represent the best-understood epi-
genetic marks (Figure 2).
hIstonE sIgnaturEs
Chromatin refers to a complex of DNA wrapped around histone 
proteins to form nucleosomes. These histone proteins are exten-
sively modified at their N-terminal tails by methylation, phos-
phorylation, acetylation, and ubiquitination as part of a histone 
signature serving to define accessibility to the DNA; densely pack-
aged “closed” chromatin is termed heterochromatin while acces-
sible “open” chromatin is termed euchromatin (Jenuwein and Allis, 
2001). Histone acetylation is known to be a predominant signal 
for active chromatin configurations while some specific histone 
methylation reactions are associated with either gene silencing or 
activation. Key to this chromatin remodeling are histone-modifying 
enzymes such as histone acetyltransferases (HAT) that acetylate 
histone tails, histone deacetylases (HDAC) which deacetylate and 
histone demethylases that remove methylation. These histone-
modifying enzymes are generally recruited through interactions 
with specific transcription factors that recognize and bind to cer-
tain cis-acting sequences in genes. In this way, signaling pathways 
registering environmental conditions and governing transcription 
factor activities, could serve as conduits for linking experiences to 
epigenetic modifications of genes.
dna MEthylatIon – thE sound of sIlEncE
DNA  methylation  refers  to  the  chemical  transfer  of  a  methyl 
group to the 5′ position of cytosine rings, usually in the context 
of  CpG  dinucleotide  sequences,  and  generally  results  in  gene 
Early lIfE carE
Shorter periods of separation in rodents (e.g., 15 min) or “han-
dling,” appear to evoke qualitative changes in maternal care and 
have consequently been found to elicit effects on behavioral and 
stress-related responses that are opposite to MS, i.e., reduced anxi-
ety and attenuated HPA axis responses to stress when tested as 
adults (for review see Fernández-Teruel et al., 2002). This result 
would  support  the  so  called “maternal  mediation”  hypothesis 
(Smotherman et al., 1974) whereby the “emotional state” of the 
mother imprints the one of the offspring.
Indeed, there appears to be a direct relationship between vari-
ations in the levels of maternal care and the development of indi-
vidual differences in the behavioral and neuroendocrine responses 
to stress of the offspring. In particular, high levels of maternal care 
appear to be directly associated with reduced behavioral and neu-
roendocrine responses to novelty in the offspring (Liu et al., 1997). 
Data from rodent models indicate that the long-term effects of 
handling appear to depend upon changes in the differentiation of 
those neurons known to curtail the stress response (Meaney et al., 
1996). These alterations include increases in GR expression in the 
hippocampus, a region strongly implicated in glucocorticoid feed-
back regulation and reduced levels of hypothalamic CRH (Plotsky 
and Meaney, 1993).
hIghEr prIMatE ModEls
Primates are particularly interesting for studying the role of environ-
mental influences during early life; most psychopathology revolves 
around social functions and, compared to rodents, non-human 
primates display complex social behaviors and structures resem-
bling humans. The mother–infant bond in primates is the most 
fundamental early relationship and, as such, primate infants dem-
onstrate remarkable similarities to humans upon separation from 
their mother, with chronic and sustained separation in infanthood 
leading to anxiety-like behaviors, cognitive impairments and long-
term alterations in the HPA axis (e.g., Sanchez et al., 2010). It is also 
possible to deploy more subtle manipulations in early life experience 
in primates. One study, increased stress experiences of the mother 
through unpredictable disruption of food availability during forag-
ing. Such hardship led to infants developing increased concentra-
tions of cerebrospinal fluid CRH, reduced cortisol levels and fearful 
behaviors when compared to control infants. Furthermore, when 
followed into young adulthood, concentrations of CRH remained 
elevated, indicating that even relatively brief disturbances of the 
maternal–infant relationship can establish long-lasting changes in 
stress response systems in monkeys (Coplan et al., 2001).
nEw answErs to old quEstIons
The aforementioned studies demonstrate that various aspects of 
the early environment can lead to dramatic changes in neurodevel-
opmental trajectories and lead to differential risk of physical and 
psychiatric disorders. However, the question remains as to how 
early life exposure to stress is able to evoke such persistent altera-
tions in neuronal substrates, hormonal regulation, and behavioral 
responses in the adult?
Cells of a multicellular organism are genetically identical but 
structurally  and  functionally  distinct  owing  to  the  differential 
expression of genes. Many of these differences in gene expression www.frontiersin.org  April 2011  | Volume 2  | Article 16  |  5
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i.e., duplicate their genome. Of the three DNA methyltransferases 
identified in mammals, DNMT1 shows preference for hemimethyl-
ated DNA in vitro, which is consistent with its role as maintenance 
DNMT, while DNMT3a and DNMT3b can methylate unmethylated 
DNA supportive of roles as de novo methylases. The activity of 
these enzymes is crucial to the vast array of developmental pro-
grams in mammals and is, therefore, tightly regulated. During early 
embryogenesis, epigenetic silencing of genes from either maternal 
or paternal origins occurs predominantly through the DNA meth-
ylation activity of the “maintenance” methyltransferase DNMT1 
while further tissue-specific gene expression and DNA methylation 
during later postnatal development requires also the activity of the 
“de novo” methyltransferases DNMT3a and DNMT3b (for review 
see Turek-Plewa and Jagodzin ´ski, 2005).
In general, the endpoint of both DNA methylation processes 
is either long-term silencing or fine-tuning of gene expression 
potential. Though methylated CpG dinucleotides can directly inter-
fere with transcription factor binding, most effects of repression 
seem to occur indirectly, via recruitment of methyl-CpG binding 
domain (MBD) proteins and their associated repressor complexes 
(for review see Jørgensen and Bird, 2002). The MBD family of 
proteins, comprising MBD1, MBD2, MBD3, MBD4, and Kaiso in 
addition to the founding member MeCP2 assemble at methyla-
tion marks to provide a platform for the recruitment of corepres-
sor complexes including HDACs that can rewrite histone marks 
silencing. Since DNA methylation represents a covalent bond, it is 
thought to be more stable than other epigenetic marks. Such CpG 
sequences are conspicuously under-represented in mammalian 
genomes with over 85% of these locating to repetitive sequences 
scattered throughout the genome and being heavily hypermethyl-
ated, possibly playing a crucial role in silencing these elements and 
thereby maintaining integrity of the genome. The remaining ∼15%, 
of CpG dinucleotides typically cluster within GC-rich regions 
known as “CpG islands” that locate within or around the promot-
ers of approximately 40% of genes in the genome (for review see 
Illingworth and Bird, 2009). Accounting for ∼1% of the genome, 
these CpG islands are largely unmethylated in the normal somatic 
cells while regions showing lower CpG density are more frequently 
methylated (Weber et al., 2007). In general, patterns of methylation 
tend to correlate with chromatin structure, i.e., active regions of 
the chromatin are associated with hypomethylated DNA whereas 
hypermethylated DNA is packaged in inactive chromatin (Razin 
and Cedar, 1977).
In mitotically active cells DNA methylation is not copied by 
the DNA replication machinery, but maintained by DNA meth-
yltransferase enzymes (DNMTs) that use S-adenosylmethionine 
as a methyl donor. The DNA methylation machinery first has to 
establish new cell-type-specific DNA methylation patterns during 
development and possibly during adulthood in response to new sig-
nals. These patterns have to be renewed once cells undergo division, 
Figure 2 | DNA wraps around histones to form a complex referred to as 
chromatin. The N-terminal tails of histones serve as sites for epigenetic marking 
by acetylation and methylation via chromatin remodeling enzymes (e.g., HDACs, 
HATs, HMTs, and HDMs). DNA methylation refers to the chemical transfer of 
methyl groups to CpG acceptor sites through a class of enzymes known DNA 
methyltransferases (DNMTs). Active marks (e.g., histone acetylation and DNA 
hypomethylation) characterize “open” chromatin, while repressive marks (e.g., 
histone methylation and DNA hypermethylation) occur at “closed” chromatin.Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    April 2011  | Volume 2  | Article 16  |  6
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expression of a large number of potentially unrelated genes, disrup-
tions in distinct epigenetic regulators seemingly lead to sympto-
matically similar mental retardation syndromes (Kramer and van 
Bokhoven, 2009). Ergo, it is conceivable that mental retardation 
does not take root in changes of specific target gene(s) but by the 
inability of concerned neurons to respond adequately to environ-
mental signals under conditions of greatly distorted transcriptional 
homeostasis (Ramocki and Zoghbi, 2008).
One  of  the  most  common  causes  of  mental  retardation  in 
females is Rett syndrome, a progressive neurodevelopmental dis-
order resulting from mutations in the methyl-CpG binding protein 
MeCP2 located on the X chromosome. Interestingly, less disrup-
tive gene mutations or alterations in expression of this gene also 
appear to underlie some cases of autism (for review see Gonzales 
and LaSalle, 2010), along with further members of the MBD fam-
ily in a small number of cases (Cukier et al., 2010). Another severe 
X-linked form of mental retardation (ATRX; alpha thalassemia/
mental retardation syndrome X-linked) results from mutations of 
a gene coding for a member of the SNF2 subgroup of a superfamily 
of proteins involved in chromatin remodeling (Picketts et al., 1996). 
Further defects affecting proteins involved in histone modifica-
tion leading to mental retardation are mutations of CBP, a protein 
with HAT function, underlying Rubinstein–Taybi syndrome (Petrij 
et al., 1995) and alterations in RSK2, involved in histone phos-
phorylation and interaction with CBP, leading to Coffin–Lowry 
syndrome, an X-linked mental retardation disorder characterized 
by psychomotor and growth retardation (Hanauer and Young, 
2002). Defects in proteins important for histone methylation are the 
H3K4-specific histone demethylase JARIDIC resulting in X-linked 
mental retardation (Jensen et al., 2005), the nuclear receptor set 
domain containing protein 1 (NSD1) gene causing Sotos syndrome 
and Weaver syndrome (Tatton-Brown and Rahman, 2007), the his-
tone lysine methyltransferase GLP/EHMT1 gene characterized by 
severe mental retardation (Kleefstra et al., 2006) and finally, MLLl, 
a H3K4-specific methyltransferase involved in hippocampal syn-
aptic plasticity, that might underlie in the cortical dysfunction of 
some cases of schizophrenia (for review see Akbarian and Huang, 
2009). The development of, often severe, mental retardation in 
these syndromes supports the importance of functional epigenetic 
machinery in the regulation of early brain development. Following 
on, it could be expected that perturbations in the regulation and 
expression of various epigenetic components might then lead to 
further mental pathologies.
altEratIons In EpIgEnEtIc rEgulatIon
There are a growing number of studies indicating aberrant epi-
genetic marks in the development of mental pathologies later in 
life, though whether changes originate during early development 
or in later life as a response to an environmental exposure remain 
important questions. For example, DNA hypomethylation at the 
promoter of the gene for catechol-O-methyltransferase (COMT), 
an enzyme regulating the level of dopamine, has been found to 
associate with schizophrenia and bipolar disorder (Abdolmaleky 
et al., 2006). At the promoter region of the RELN gene, encoding 
a protein implicated in long-term memory, a number of stud-
ies have evidenced hypermethylation, correlating with reduced 
expression, in schizophrenia (e.g., Grayson et al., 2005). Within 
evoking subsequent chromatin compaction and transcriptional 
suppression. These complexes can additionally recruit DNMTs to 
promote, maintain and enforce gene repression, compatible with 
a reciprocal cross talk between DNA methylation and chromatin 
marks in the regulation of gene transcription.
Although promoter and enhancer regions appear to attract most 
attention in regard to DNA methylation and gene transcription, 
it is becoming increasingly clear that methylation at other gene 
elements play important regulatory roles. For example, increased 
DNA methylation within the body of genes is typically associated 
with active transcription (Ball et al., 2009), while DNA methylation 
at 3′ and intragenic regions may play distinct roles on regulating 
gene expression (for review see Suzuki and Bird, 2008), possibly 
controlling activity of intragenic non-coding RNAs. Non-coding 
RNA are functional RNA molecules that are not translated into a 
protein and can be involved in a variety of RNA-mediated silencing 
pathways with increasing evidence indicating that the regulation of 
these factors could play key roles in neural development and in neu-
ropsychiatric disorders (for review see Qureshi and Mehler, 2010).
As a final point, a new epigenetic mark, 5-hydroxymethylcy-
tosine, has been recently discovered and hailed as the “6th base.” 
This modification of CpG dinucleotides appears to be particularly 
abundant in human and mouse brains and to increase during aging 
in mouse hippocampus and cerebellum (e.g., Song et al., 2011). 
Considering that it can be generated by enzymatic oxidation of 
methylated cytosine residues, it appears possible that such modi-
fications might regulate gene expression, though any possible role 
in brain development or function has yet to be explored in detail.
thE EMErgIng rolE of EpIgEnEtIcs In MEntal hEalth
The billions of neurons in a single brain have the same DNA 
sequence yet are differentiated for their diverse functions through 
epigenetic programming during pre- and postnatal development 
and possibly throughout life. Epigenetic mechanisms are therefore 
gatekeepers to brain development, differentiation and maturation, 
and ultimately, associated disease processes.
gEnEtIc dEfEcts In thE EpIgEnEtIc MachInEry
Deregulation of epigenetic pathways can lead to either silencing 
or inappropriate expression of specific sets of genes manifesting 
with diseases. A growing understanding in this field is leading to 
the identification of an expanding number of epigenetic diseases 
comprising various cancers, neurodegenerative disease, syndromes 
characterized by chromosomal instabilities, mental retardation, and 
imprinting disorders (for review see Halusková, 2010).
In the nervous system epigenetic marks govern basic cellular 
processes such as synaptic plasticity and complex behaviors like 
memory and learning. Genetic defects in the epigenetic machin-
ery, triggering faulty marking, can lead to severe defects in brain 
development, and manifest as devastating diseases such as the 
Rett syndrome, Rubinstein–Taybi syndrome, Fragile X syndrome, 
Alzheimer’s disease, Huntington’s disease, and psychiatric disor-
ders such as autism, schizophrenia, addiction, and depression (for 
review see Grafodatskaya et al., 2010).
There are a large number of genes encoding epigenetic regulators 
that, when mutated, can give rise to mental retardation. Though one 
might assume that different epigenetic factors would   orchestrate the www.frontiersin.org  April 2011  | Volume 2  | Article 16  |  7
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dysregulation with age appears to be a highly tissue-dependent 
phenomenon. Furthermore, there appear to be subsets of genes 
that are tissue-specifically affected by age-associated DNA meth-
ylation changes, such as genes involved in metabolism and meta-
bolic regulation in liver and visceral adipose tissues (Thompson 
et al., 2010) or CpG sites physically close to genes involved in 
DNA binding and regulation of transcription in various brain 
regions (Hernandez et al., 2011). This later study provides a par-
ticularly strong argument that specific age-related DNA methyla-
tion changes may have quite broad impacts on gene expression in 
the human brain. We may, however, have to readdress some of our 
preconceptions regarding age and aging in relation to epigenetic 
changes concerning a new study of various mouse tissues in which 
a majority of DNA methylation changes found in adulthood were 
preceded by similar DNA methylation changes in juveniles, and 
that the expression levels of genes near progressively methylated 
and demethylated CpG sites were already significantly up- or 
down-regulated, respectively, in young mice (Takasugi, 2011). 
This would imply that the epigenome maturates continuously 
throughout lifespan and that affects of aging emerge gradually 
over time.
Compatible with this view, a growing number of reports in 
the literature challenge the conventional view of a locked state 
for DNA methylation, demonstrating that DNA methylation 
remains an active process in post-mitotic cells (i.e., neurons). For 
example, DNMTs are expressed and regulated in the adult brain 
(e.g., Brown et al., 2008) and evidence continues to mount that 
epigenetic mechanisms are able to dynamically control changes 
in gene activity throughout the lifespan as a result of exposure 
to a variety of environmental factors during aging, as previously 
described.
Overall, these findings suggest the presence of several mecha-
nisms regulating methylation that are possibly adjusted at different 
steps during development, maturation and aging by processes that 
are responsive to numerous environmental and genetic factors.
thE EpIgEnoME and Early lIfE advErsIty
Aside from controlling constitutive gene expression, epigenetic 
mechanisms can also serve to fine-tune gene expression potential 
in response to environmental cues. DNA methylation has been 
the most studied in regard to understanding early life experiences 
and the epigenetic programming of their neurobiological sequelae. 
Indeed, the stable nature of DNA methylation renders it an ideal 
template for underpinning sustained gene effects controlling brain 
function and behavior from early development to old age. Thus we 
and others have proposed that conditions of early life environment 
can evoke changes in DNA methylation facilitating epigenetic pro-
gramming of critical genes involved in regulating stress responsivity 
that may in turn manifest with neuroendocrine and behavioral 
symptoms in adulthood (e.g., McGowan et al., 2009; Murgatroyd 
et al., 2010a; Figure 3).
MatErnal carE and EpIgEnEtIc prograMMIng of gr
One well-characterized model established to study the effects of 
early life environment on stress programming examines variations 
in the quality of early postnatal maternal care, as measured by levels 
of licking and grooming. Studies revealed that rat pups receiving 
the frontopolar cortex, a further study discovered DNA hypermeth-
ylation at the gamma-aminobutyric acid receptor alpha1 subunit 
(GABA-A) promoter region, in suicide and MDD brains that cor-
related with altered DNMT mRNA expression (Poulter et al., 2008), 
while another investigation reported alterations in DNA methyla-
tion and mRNA expression of the peptidylprolyl isomerase E-like 
(PPIEL) gene in monozygotic twins discordant for bipolar disorder 
(Kuratomi et al., 2008).
Monozygotic  twin  pairs  share  a  virtually  identical  genome 
though may differ to various extents in their pre- and postnatal 
environments, making them highly informative in understanding 
how epigenetic variation could affect complex traits (for review 
see Bell and Spector, 2011). Indeed, twins frequently differ in their 
prevalence of mental disorders with a number of studies report-
ing differences in DNA methylation between monozygotic twins 
discordant for schizophrenia (e.g., Petronis et al., 2003) and a more 
recent report detecting lower levels of DNA methylation in the tem-
poral cortex of Alzheimer-affected twins (Mastroeni et al., 2009). A 
further genome-wide screen detected substantial variability in DNA 
methylation between twins (Kaminsky et al., 2009), which may 
relate to the earlier findings, in which DNA methylation profiles 
of young monozygotic twin pairs were shown to be more epige-
netically similar than older monozygotic twins (Fraga et al., 2005). 
This would therefore suggest that epigenetic changes increase with 
age, following the view that epigenetic mechanisms such as DNA 
methylation deteriorate with age and may even accelerate the aging 
process (Murgatroyd et al., 2010b; Rodríguez-Rodero et al., 2010). 
However, the influence of genetic factors should also be considered 
as reports have found higher epigenetic variation in dizygotic than 
in monozygotic twins (Kaminsky et al., 2009) and intra-individual 
changes in DNA methylation showing degrees of familial clustering 
(Bjornsson et al., 2008). Finally, the possible influence of random 
stochastic factors may further complicate such studies with reports 
that even genetically identical laboratory animals living under the 
same controlled environmental conditions, nevertheless develop 
phenotypic and epigenetic differences (e.g., Vogt et al., 2008).
EpIgEnEtIcs and agIng
The relationship between DNA methylation and aging was origi-
nally proposed by Berdyshev, who discovered that genomic global 
DNA methylation decreases with age in spawning humpbacked 
salmon (Berdyshev et al., 1967). This was later backed-up by fur-
ther evidence for the presence of gradual global losses of methyla-
tion in various mouse, rat, and human tissues (e.g., Fuke et al., 
2004). Much of this global hypomethylation may result from the 
fact that different types of interspersed repetitive sequences, that 
make up the major bulk of genomes, appear to be targeted at single 
time-points to varying degrees by age-associated hypomethyla-
tion (Jintaridth and Mutirangura, 2010). In general terms, age-
associated hypermethylation is thought to preferentially affect loci 
at CpG islands, while loci devoid of CpG islands lose methylation 
with age. Although an increase in promoter methylation with 
aging is generally accepted, such as from studies in human prostate 
and colon tissues (e.g., Kwabi-Addo et al., 2007), recent evidence 
from Bjornsson et al. suggest a more complex picture with both 
increases and decreases in intra-individual global methylation 
levels over time (Bjornsson et al., 2008). Certainly, epigenetic Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    April 2011  | Volume 2  | Article 16  |  8
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exposed to early life adversity, or patients suffering from major 
depression only, revealed no epigenetic marking of hippocampal 
GR (Alt et al., 2010).
MatErnal sEparatIon strEss and EpIgEnEtIc prograMMIng of 
avp
Work in our lab evidenced that MS stress in mice, involving 
separating pups from their mothers for 3 h each day during the 
first 10 days of life, induced life-long sustained expression of 
hypothalamic AVP underlying elevated corticosterone secretion, 
heightened endocrine responsiveness to subsequent stressors, 
and altered feedback inhibition of the HPA axis. Starting at 
10 days of life, directly following the period of MS, and lasting 
for at least 1 year, elevated AVP expression was specific to the 
parvocellular subpopulation of PVN neurons while hypotha-
lamic CRH and hippocampal GR expression remained unal-
tered.  Importantly,  this  altered  expression  associated  with 
reduced levels of DNA methylation in the PVN at particular 
CpG dinucleotides within an enhancer region important for AVP 
gene activity (Murgatroyd et al., 2009). We further showed that 
hypomethylation at this region reduced the ability of MeCP2 to 
bind and recruit repressive histone complexes such as HDACs 
and DNMTs (Murgatroyd, unpublished), supporting previous 
evidences for a role of MeCP2 as an epigenetic platform upon 
which  histone  deacetylation,  H3K9  methylation,  and  DNA 
methylation are carried out to confer transcriptional repression 
and gene silencing (e.g., Murgatroyd et al., 2010a).
We then examined the signals controlling MeCP2 occupancy 
at  this  early  step.  Experience-driven  synaptic  activity  causes 
membrane depolarization and calcium influx into select neu-
rons, which in turn induce a wide variety of cellular responses, 
connecting neuronal activity to transcriptional regulation (Greer 
and Greenberg, 2008). Furthermore, neuronal depolarization has 
previously been shown to trigger Ca2+-dependent phosphoryla-
tion of MeCP2, causing dissociation of MeCP2 from the BDNF 
promoter and consequently gene derepression (e.g., Martinowich 
et al., 2003). Subsequent studies revealed that CaMKII (Ca2+/
calmodulin-dependent protein kinase II) was able to mediate 
this phosphorylation of rat MeCP2 at serine 421 (Zhou et al., 
2006), and the homologous serine residue 438 in the mouse 
(Murgatroyd  et  al.,  2009).  Analysis  of  10-day-old  early  life 
stressed mice revealed increased CaMKII and phospho-MeCP2 
immunoreactivity that promoted MeCP2 dissociation at the AVP 
enhancer and depression. However, though early life stressed 
mice tested in adulthood (6 week) still showed reduced MeCP2 
binding at the AVP enhancer, the levels of MeCP2 phosphoryla-
tion and CaMKII activation in the PVN no longer differed to 
those of control animals. Instead, evolving differences in DNA 
methylation at this region underlie reduced MeCP2 occupancy 
in early life stressed mice. Taken together, the initial stimulus of 
early life stress initiates a loss of MeCP2 occupancy that subse-
quently leads to the hard-coding of the early life experience at 
the level of DNA methylation (Figure 4). Interestingly, in the 
control  mice  an  age-associated  demethylation  also  occurred 
though, critically, the region of the enhancer marked by early 
life stress was spared, supporting, the importance of this region 
in AVP regulation (Murgatroyd et al., 2010b).
high levels of maternal care during early life developed sustained 
elevations in GR expression within the hippocampus and decreased 
hippocampal sensitivity to glucocorticoid hormones (Liu et al., 
1997). In addition, these rats showed decreased hypothalamic CRH 
levels and reduced HPA axis responses to stress (Francis et al., 1999) 
when compared to animals reared by mothers showing low levels 
of maternal care. Analysis of the molecular mechanisms underlying 
the long-lasting programming of the GR revealed an important 
role for epigenetic regulation. The investigators evidenced that the 
enhanced hippocampal GR expression in animals receiving high 
levels of maternal care associated with a persistent DNA hypometh-
ylation at specific CpG dinucleotides within the hippocampal GR 
exon 17 promoter and increased histone acetylation. These epi-
genetic modifications facilitated binding of the transcriptional 
activator nerve growth factor-inducible protein A (NGF1a) to 
this region, providing a plausible mechanism for the epigenetic 
programming of gene function by maternal care during early life 
(Weaver et al., 2004). Interestingly, a further study using a different 
paradigm of MS in another species of rat found that corticosterone 
release and increased NGF1a expression failed to induce changes 
in DNA methylation levels at the same hippocampal GR promoter 
(Daniels et al., 2009), supporting again the idea that variations in 
the genetic make up, and environmental disparities, are critical 
determinants in organization of the epigenome. In support of this 
idea, subsequent studies detected altered GR promoter methylation 
in human postmortum hippocampal tissue of depressed suicide 
patients who suffered from a history of early life abuse and neglect 
(McGowan et al., 2009). In contrast, suicide patients who were not 
Figure 3 | early life experience can persistently alter expression levels of 
key genes through epigenetic marking which can underpin changes in 
behavior, neuroendocrine, and stress responsivity throughout later life. 
Collectively, this process is referred to as epigenetic programming. The nature 
of the environment throughout later life, in addition to the impact of biological 
processes associated with aging and genetic sex, may exacerbate the effects 
of programming established during early life resulting in increased vulnerability 
to mood disorders.www.frontiersin.org  April 2011  | Volume 2  | Article 16  |  9
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HPA axis by early life experiences extends to the pituitary gland 
(POMC) in addition to hippocampal (GR) and hypothalamic (AVP 
and CRH) tissues.
EpIgEnEtIc prograMMIng bEyond thE hpa axIs
Aside from the HPA axis, additional pathways and epigenetic targets 
of early life stress seem to exist. For example, rats reared in a hos-
tile postnatal environment exhibited promoter hypermethylation 
associating with reduced expression of brain-derived neutrotrophic 
factor (BDNF) in the prefrontal cortex in adulthood (Roth et al., 
2009). BDNF is a neurotrophin that regulates neurodevelopment, 
neuroplasticity, and neuronal functions. It is further involved in 
the pathogenesis of psychiatric and neurodegenerative disorders 
and there is a growing body of literature linking epigenetic gene 
regulation of the BDNF gene with brain plasticity and cognitive 
function (e.g., Lubin et al., 2008).
Neuroendocrine  systems  associated  with  female  sexual  and 
maternal behavior and the development of the GABA system also 
appear to be influenced by alterations in the early life environment. 
Female rat offspring of high-maternal care mothers developed a 
hypomethylation of the estrogen receptor-alpha (ERα) promoter 
in the medial preoptic area correlating with increased binding 
of the transcription factor STAT5 and elevated ERα expression 
addItIonal targEts for EpIgEnEtIc prograMMIng of thE hpa 
axIs
A growing number of studies support the role of epigenetic modi-
fications in the control of genes regulating the HPA axis. Two 
recent ones demonstrate epigenetic programming of hypotha-
lamic CRH in response to stress in either the prenatal period or 
during adulthood. Pregnant mice subjected to chronic variable 
stressors during early gestation revealed a hypomethylation at the 
CRH promoter in the hypothalamus of the offspring in adult-
hood (Mueller and Bale, 2008). Moreover, chronic social stress 
in adult mice caused a hypomethylation of the CRH promoter 
in the PVN of a subset of animals displaying subsequent social 
avoidance (Elliott et al., 2010).
A number of studies describe epigenetic regulation of the POMC 
gene (pro-opiomelanocortin, coding for ACTH), which is a down-
stream target of AVP and CRH signaling. Hypermethylation of the 
promoter region leads to silencing of expression that appears to be 
regulated by cortisol (e.g., Mizoguchi et al., 2007). Recent studies 
suggest epigenetic programming of POMC by nutritional cues such 
as overfeeding or anorexia (e.g., Ehrlich et al., 2010), while other 
research suggested an association with alcohol craving (Muschler 
et al., 2010). These preliminary findings warrant further studies to 
address the question of whether epigenetic programming of the 
Figure 4 | experience-dependent activation of neurons in the PVN during early life inhibits MeCP2 binding to and repressing the AVP gene in stressed 
mice. This further favors DNA hypomethylation underpinning reduced MeCP2 occupancy at the AVP enhancer and maintaining epigenetic control of AVP expression 
into later life.Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    April 2011  | Volume 2  | Article 16  |  10
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  necessary to establish a causal link for this epigenetic modifica-
tion to general depressive behavior in humans. Furthermore, an 
independent follow-up study failed to identify similar DNA meth-
ylation at the GR promoter or alterations in major depression (Alt 
et al., 2010), again pointing to the importance of inter-individual 
genetic and environmental variations.
Overall, these studies suggest that epigenetic processes could 
mediate the effects of the early environment on gene expression 
and that stable epigenetic marks such as DNA methylation might 
then persist into adulthood and influence vulnerability for psycho-
pathology through effects on intermediate levels of function such 
as activity of the HPA axis.
futurE rEsEarch
With the advent of new high-throughput sequencing technologies 
research is now beginning to move on from the single-gene scale 
to epigenome-wide analyses of all epigenetic marks throughout a 
genome in a specific tissue. Given that epigenetic modifications are 
sensitive to changes in the environment, it might be anticipated 
that these efforts will identify epigenomic signatures for mental 
disorders and molecular dysregulations resulting from early life 
stress (Albert, 2010). While such a strategy appears highly attrac-
tive in the field of cancer research addressing clonally expanded 
cell populations, rather than heterogenous tissues, the field of 
epigenetic association studies in mental illnesses might be more 
challenging. Epigenetic modifications reported to date in animal 
models and postmortem brain tissues are seldom “all or none” but 
gradual, and seem to occur in a highly cell-type-specific manner. 
In this view, the extraordinary complexity and heterogeneity of 
neural tissues poses a major hurdle to derive epigenetic biomarkers 
in psychiatric disease.
EpIgEnEtIc bIoMarkErs
Ultimately, the identification of “epigenetic biomarkers” in dis-
tinct genomic regions may provide important information for the 
understanding of biological processes underlying mental diseases 
and thus allow for the development and design of new therapeutics. 
Though expression and DNA methylation changes in the brain 
are more obviously relevant to changes in behavior, comparable 
changes in blood might provide a clinically valuable surrogate, 
given the easy access to this tissue in patients. Some early studies 
have shown partial correlations in gene expression between vari-
ous brain regions and blood (e.g., Brown et al., 2001), which have 
been supported by following data demonstrating epigenetic differ-
ences in lymphocytes associating with the brain in Rett syndrome 
and Alzheimer’s disease (e.g., Wang et al., 2008). Recently it was 
described that chronic corticosterone exposure in mice stimulated 
parallel increases in FKBP5 expression between brain tissues and 
blood together with some, generally subtle, alterations in DNA 
methylation at the promoter of this gene (Lee et al., 2010). However, 
the other candidate HPA axis genes tested in this study – namely, 
NR3C1, HSP90, CRH, and CRHR1 – failed to show such effects 
while further studies in this area of research also describe little 
correlation (e.g., Yuferov et al., 2011). Consequently, the prospect 
of diagnostic epigenetic testing for mental diseases using mark-
ers in the blood appears so far unresolved, and certainly further 
research is required.
(Champagne et al., 2006). This study indicates that epigenetic pro-
gramming can take place in a sex-specific manner which could shed 
new light on the long standing question of a sex bias in numer-
ous diseases (for review see Menger et al., 2010) Additionally, rat 
pups receiving high-maternal care showed enhanced hippocam-
pal  glutamic  acid  decarboxylase  1  (GAD1)  mRNA  expression, 
decreased cytosine methylation, and increased histone 3-lysine 9 
acetylation (H3K9ac) of the GAD1 promoter (Zhang et al., 2010). 
Furthermore, DNMT1 expression was also significantly lower in 
the offspring of those rats that received high-maternal care (Zhang 
et al., 2010). This is interesting, as a number of studies suggest the 
regulation of components of the epigenetic machinery in response 
to stressors. For example, recent work has shown that chromatin 
remodeling in various brain regions, including the hippocampus, 
is associated with the effects of stress in a variety of models (e.g., 
Hunter et al., 2009).
Digressing from the literature of early life induced epigenetic 
changes; one recent study found that traumatic stress during adult-
hood can also drive epigenetic changes in the brain. Adult rats 
exposed to severe chronic psychosocial stress showed increased 
BDNF promoter methylation in the hippocampal regions associat-
ing with reduced expression of this gene (Roth et al., 2011). Another 
neurotrophin known to be important for the regulation of brain 
plasticity and implicated in depression, is glial cell-derived neuro-
trophic factor (GDNF). Examining two genetically distinct mouse 
strains exhibiting different behavioral responses to chronic stress, 
researches recently discovered GDNF in the nucleus accumbens 
to be epigenetically silenced following adulthood stress only in 
the stress-vulnerable mice (Uchida et al., 2011), again support-
ing the importance of dynamic epigenetic changes in response to 
environmental cues lasting into adulthood.
clInIcal studIEs of EpIgEnEtIc prograMMIng by Early lIfE 
advErsIty
Evidence is beginning to emerge that the findings of epigenetic 
programming in animal models may extrapolate to human stud-
ies and psychopathologies associated with severe abuse or neglect 
during childhood. McGowan et al. (2008) found that suicide 
subjects who had a history of early childhood neglect or abuse 
exhibited with hypermethylation at the ribosomal RNA (rRNA) 
promoter. rRNA genes encode ribosomal RNA, important for 
protein synthesis, leading to the consideration that such reduc-
tions in rRNA levels might reflect a reduced capacity for protein 
synthesis in the hippocampus of suicide victims. Though how 
this may contribute to the pathology is yet to be determined. 
Subsequent studies of postmortum tissue by the same researchers 
further evidenced a hypermethylation of the GR gene promoter 
among suicide victims with a history of abuse in childhood, but 
not among controls or suicide victims who did not suffer such 
early life stress (McGowan et al., 2009). This data appear consist-
ent with previous studies demonstrating that the epigenetic status 
of the homologous GR gene promoter is regulated by parental care 
during early postnatal development in rats (Weaver et al., 2004). 
Although indirect, this correlation in the human study suggests 
that epigenetic mechanisms, thought to play a role in vulner-
ability to stress-related conditions in rodents, might extrapolate 
to humans. However, it should be noted that further work is www.frontiersin.org  April 2011  | Volume 2  | Article 16  |  11
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expression of glucocorticoid   receptor 
are being used, show significant improvements in behavior and 
cortisol regulation (e.g., Fisher et al., 2007). A further study in 
foster children has revealed that a relational-based intervention 
focused more on social interactions with caregivers proved to be 
far more efficient in reducing cortisol levels when compared to an 
intervention focused more on enhancing cognitive skills (Dozier 
et al., 2008), bringing us back to the importance of the early 
life attachment system. Considering these observations, further 
preclinical studies addressing the effects of such environmental 
enrichment following early life stress could focus on whether 
critical time-windows exist for heightened sensitivity to stress, 
bearing in mind the temporal aspects of brain development and 
epigenetic mechanisms, and adaptability to ameliorative effects 
of an enriched environment.
A further option to modify the effects of early life stress could 
be to target DNMTs and chromatin remodeling enzymes. Though 
such histone-modifying and DNA methylation-targeting drugs are 
proving highly attractive to cancer therapeutics, it remains to be 
seen whether they have any real potential in the realm of psychi-
atric diseases. Nonetheless, it is notable that the frequently used 
mood stabilizer valproate (VPA) has been shown to modulate the 
epigenome by inhibiting HDACs and can additionally promote 
demethylation in brain cells (e.g., Perisic et al., 2010). However, 
much caution centers on the fact that most currently available “epi-
genetic drugs” suffer from a lack of specificity at both the levels of 
tissue and the genome. This field may yet advance with research 
targeting specific histone-modifying enzymes, such as G9a, that 
may be selective enough to ameliorate addiction or mental illness 
(Maze et al., 2010). Another interesting approach to regulate meth-
ylation relies on treatment with the methyl donor l-methionine, or 
folic acid supplementation during gestation. Intriguingly, there are 
a number of recent reports linking low folate levels during preg-
nancy with behavioral symptoms in children (e.g., Schlotz et al., 
2010). Although effects in gene expression and behavior have been 
reported (e.g., Weaver et al., 2005), the mechanisms of how such 
treatment could be able to target and induce such effects in specific 
regions of the brain is still yet not properly understood.
In sum, understanding how early life experiences can give rise to 
lasting epigenetic memories conferring increased risk for mental dis-
orders is emerging at the epicenter of modern psychiatry. Whether 
suitable social or pharmacological interventions could reverse del-
eterious epigenetic programming triggered by adverse conditions 
during early life, should receive highest priority on future research 
agendas. Progress in this field will further garner public interest, 
a general understanding and appreciation of the consequences of 
childhood abuse and neglect for victims in later life.
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a MattEr of tIMIng
Many of the studies surveyed in this review highlight the impor-
tance of the temporal nature of brain developmental processes in 
relation to the effects that environmental stressors can have on 
epigenetic programming of long-term changes in neurodevelop-
ment and behavior. Developing brain regions typically pass through 
critical “windows” of sensitivity that stretch over different perinatal 
periods. Therefore, it stands to reason that the impact of stressors 
at different time-points will confer more pronounced and long-
lasting effects within brain regions that are actively developing at 
that particular time. For example, late prenatal and early postnatal 
life is the critical period for hippocampal development, possibly 
explaining why environmental exposures during this time strongly 
associate  with  cellular,  morphological  and  epigenetic  changes 
within these structures (for review see McCrory et al., 2010). In 
contrast, environmental exposures during later life tend to con-
fer their phenotypic effects by altering other areas of the brain. 
For example, repeated restraint stress in adult rats fails to cause 
long-term hippocampal-related effects such as those observed fol-
lowing similar stress exposure during prenatal and early postnatal 
life (Conrad et al., 1999). On the other hand, substantial cortical 
development and differentiation is known to continue well into 
adolescence (e.g., Wang and Gao, 2009), possibly explaining why 
these regions are more susceptible to epigenetic changes in response 
to later life environmental factors.
In addition to the temporal nature of brain development, we 
should also consider the temporal and gene-specific manner in 
which epigenetic marks are established. This will be of crucial 
importance in understanding how experience-dependent epige-
netic marks may undergo the transition from a preliminary labile 
state to a hard-coded stable print. Indeed, in our studies epigenetic 
marking of the methylation landmarks in the AVP enhancer per-
sisted under vasopressin receptor blockade in adult (3 month) mice 
consistent with the concept that the early life stress had already 
engraved a lasting cellular memory (Murgatroyd et al., 2010a). 
The question however remains of whether critical “windows” for 
timely psychotherapeutic and pharmacological interventions fol-
lowing exposure to severe trauma might exist at periods prior to the 
establishment of stable epigenetic marks. In this view, therapeutic 
interventions might then re-stimulate or inhibit those same neu-
rons and genes epigenetically programmed earlier in life and reverse 
these changes. Apparently, timing, quality and duration of such 
environmental stimulations might be highly specific and context-
dependent in regard to the exact nature of the early life stressor.
Nevertheless, studies in rats have demonstrated that envi-
ronmental enrichment during puberty can alleviate some of the 
anxiety-related effects of ELS (e.g., Imanaka et al., 2008). This 
result appears consistent with observations from the clinic. For 
example, infants who have experienced previous maltreatment, 
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